Market Research Logo

Global Coronary Stents Market Outlook, 2007 - 2020

Global Coronary Stents Market Outlook, 2007 - 2020

The global coronary stent market is expected grow, despite the current downward trend in the US, the largest market, and declining selling prices globally.
The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications.
The stent market globally and in the developed nations is largely controlled by three players—Abbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume.
This comprehensive, 465 page global strategic business report is authored by team of sector analysts who used rigorous primary and secondary research, robust analytical model to provide strategic insight and to forecast in for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies.
It provides data at global, continents, economic zones, and country level

  • Market size of coronary stents in terms - value and volume (2007-2020) for BMS, DES and Bioabsorbables (Bioresorbable – BVS)
  • Market growth rates (2007-2020)
  • Average prices of various stents in all the covered geographies (2007-2020)
  • Number of PCI procedures
  • Analytical comparison between different continents and economic regions
  • Market dynamics – market trends, drivers, restrains, issues, competitive landscape
  • Detailed pipeline and clinical studies
  • Product approval status - major geographies
  • Industry consolidation, partnerships, product launches, approvals and recalls
  • Detailed company profiles of around 70 companies from different levels of value chain
This report is useful for
  • Market expansion and market entry strategy
  • Product, production and inventory planning
  • Product management
  • Management and investors presentations
  • Due diligence to identify targets for M&A
  • Identifying in-licensing and out-licensing partners
  • Tracking present and future competition
  • Venture capitalists, Investment banks, Angel investors
  • Management consultants
  • Governments, trade and commerce organizations
  • Research institutes
How this report is different
  • Wide coverage of geographies
  • Bottom-up approach
  • Companies from various levels of value chain
  • Detailed presentation of pipeline and clinical studies
  • Projections based on detailed and rigorous primary research to validate optimistic and pessimistic approach
  • Used advanced computational, robust statistical and analytical models
  • Considered mid and late stage assets


1.Table Of Contents
1.1 List of Charts
1.2 List of Tables
2.Executive Summary
3.Market at a Glance
4.Introduction to Stents
4.1Introduction
4.1.1Classification of Stents
4.1.2Timeline for stents
5.Coronary Stents
5.1 Introduction
5.1.1 Coronary stents are primarily classified based on material used and its content
5.1.2 Characteristics and Complications of Coronary Stents
5.1.3 Materials Used in Coronary Stents
5.1.4 Market Drivers
5.1.5 Players in the Market
6.Types of Stents
6.1Estabilished
6.2Newer Generation Stents – Bioactive and Bioabsorbable Stents
7.Approvals
8.Competitive Landscape
9.Clinical Studies
10.Coronary Stents - Market Drivers and Restrains
11.Overview: Market trends
12.Approvals Driving the Growth
13.Market Data
13.1The Global Market for Coronary Stents (2007-2020)
13.1.1Global Coronary Stents Market Size - Value and Volume, 2007-2020
13.1.2Coronary Stents Devices Cross Geography Analysis, 2007-2020 for Revenue
13.1.3Coronary Stents Devices Revenue, 2007-2020
13.1.4Global Coronary Stents Revenue by Stent Type 2007-2020
13.1.5Coronary Stents Devices Cross Geography Analysis, 2007-2020 for Volume
13.1.6Global Coronary Stents Volume, 2007-2020
13.1.7Global Coronary Stents Volume by Stent Type 2007-2020
13.1.8The Global Coronary Stents Company Shares, 2014
13.2Americas Market for Coronary Stents (2007-2020)
13.2.1Americas Coronary Stents Devices Cross Country Analysis
13.2.2Americas Coronary Stents Company Shares, 2014
13.3US Market for Coronary Stents Devices (2007-2020)
13.3.1US Coronary Stents Cross Segment Analysis
13.3.2US Coronary Stents Revenue ($mn) by Segment
13.3.3Coronary Stents Volume (‘000) by Sub-Segment
13.3.4Coronary Stents Average Prices ($)
13.3.5US Coronary Stents Company Shares, 2014
13.4Canada Market for Coronary Stents Devices (2007-2020)
13.4.1Canada Coronary Stents Devices Cross Segment Analysis
13.4.2Canada Coronary Stents Revenue ($mn) by Segment
13.4.3Coronary Stents Volume (‘000) by Segment
13.4.4Coronary Stents Average Prices ($)
13.4.5Canada Coronary Stents Company Shares, 2014
13.5Brazil Market for Coronary Stents Devices (2007-2020)
13.5.1Brazil Coronary Stents Devices Cross Segment Analysis
13.5.2Brazil Coronary Stents Revenue ($mn) by Segment
13.5.3Coronary Stents Volume (‘000) by Segment
13.5.4Coronary Stents Average Prices ($)
13.5.5Brazil Coronary Stents Company Shares, 2014
13.6Argentina Market for Coronary Stents Devices (2007-2020)
13.6.1Argentina Coronary Stents Devices Cross Segment Analysis
13.6.2Argentina Coronary Stents Revenue ($mn) by Segment
13.6.3Coronary Stents Volume (‘000) by Segment
13.6.4Coronary Stents Average Prices ($)
13.6.5Argentina Coronary Stents Company Shares, 2014
13.7Europe Market for Coronary Stents (2007-2020)
13.7.1EUROPE Coronary Stents Devices Cross Country Analysis
13.7.2EUROPE Coronary Stents Company Shares, 2014
13.8 Germany Market for Coronary Stents Devices (2007-2020)
13.8.1Germany Coronary Stents Devices Cross Segment Analysis
13.8.2Germany Coronary Stents Revenue ($mn) by Segment
13.8.3Coronary Stents Volume (‘000) by Segment
13.8.4Coronary Stents Average Prices ($)
13.8.5Germany Coronary Stents Company Shares, 2014
13.9France Market for Coronary Stents Devices (2007-2020)
13.9.1France Coronary Stents Devices Cross Segment Analysis
13.9.2France Coronary Stents Revenue ($mn) by Segment
13.9.3Coronary Stents Volume (‘000) by Segment
13.9.4Coronary Stents Average Prices ($)
13.9.5France Coronary Stents Company Shares, 2014
13.10 Italy Market for Coronary Stents Devices (2007-2020)
13.10.1Italy Coronary Stents Devices Cross Segment Analysis
13.10.2Italy Coronary Stents Revenue ($mn) by Segment
13.10.3Coronary Stents Volume (‘000) by Segment
13.10.4Coronary Stents Average Prices ($)
13.10.5Italy Coronary Stents Company Shares, 2014
13.11 UK Market for Coronary Stents Devices (2007-2020)
13.11.1UK Coronary Stents Devices Cross Segment Analysis
13.11.2UK Coronary Stents Revenue ($mn) by Segment
13.11.3Coronary Stents Volume (000) by Segment
13.11.4Coronary Stents Average Prices ($)
13.11.5United Kingdom Coronary Stents Company Shares, 2014
13.12 Spain Market for Coronary Stents Devices (2007-2020)
13.12.1Spain Coronary Stents Devices Cross Segment Analysis
13.12.2Spain Coronary Stents Revenue ($mn) by Segment
13.12.3Coronary Stents Volume (‘000) by Segment
13.12.4Coronary Stents Average Prices ($)
13.12.5Spain Coronary Stents Company Shares, 2014
13.13 Belgium Market for Coronary Stents Devices (2007-2020)
13.13.1Belgium Coronary Stents Devices Cross Segment Analysis
13.13.2Belgium Coronary Stents Revenue ($mn) by Segment
13.13.3Coronary Stents Volume (‘000) by Segment
13.13.4Coronary Stents Average Prices ($)
13.13.5Belgium Coronary Stents Company Shares, 2014
13.14 Netherlands Market for Coronary Stents Devices (2007-2020)
13.14.1Netherlands Coronary Stents Devices Cross Segment Analysis
13.14.2Netherlands Coronary Stents Revenue ($mn) by Segment
13.14.3Coronary Stents Volume (‘000) by Segment
13.14.4Coronary Stents Average Prices ($)
13.14.5Netherlands Coronary Stents Company Shares, 2014
13.15 Russia Market for Coronary Stents Devices (2007-2020)
13.15.1Russia Coronary Stents Devices Cross Segment Analysis
13.15.2Russia Coronary Stents Revenue ($mn) by Segment
13.15.3Coronary Stents Volume (‘000) by Segment
13.15.4Coronary Stents Average Prices ($)
13.15.5Russia Coronary Stents Company Shares, 2014
13.16 Poland Market for Coronary Stents Devices (2007-2020)
13.16.1Poland Coronary Stents Devices Cross Segment Analysis
13.16.2Poland Coronary Stents Revenue ($mn) by Segment
13.16.3Coronary Stents Volume (‘000) by Segment
13.16.4Coronary Stents Average Prices ($)
13.16.5Poland Coronary Stents Company Shares, 2014
13.17 Switzerland Market for Coronary Stents Devices (2007-2020)
13.17.1Switzerland Coronary Stents Devices Cross Segment Analysis
13.17.2Switzerland Coronary Stents Revenue ($mn) by Segment
13.17.3Coronary Stents Volume (‘000) by Segment
13.17.4Coronary Stents Average Prices ($)
13.17.5Switzerland Coronary Stents Company Shares, 2014
13.18 Sweden Market for Coronary Stents Devices (2007-2020)
13.18.1Sweden Coronary Stents Devices Cross Segment Analysis
13.18.2Sweden Coronary Stents Revenue ($mn) by Segment
13.18.3Coronary Stents Volume (‘000) by Segment
13.18.4Coronary Stents Average Prices ($)
13.18.5Sweden Coronary Stents Company Shares, 2014
13.19 Austria Market for Coronary Stents Devices (2007-2020)
13.19.1Austria Coronary Stents Devices Cross Segment Analysis
13.19.2Austria Coronary Stents Revenue ($mn) by Segment
13.19.3Coronary Stents Volume (‘000) by Segment
13.19.4Coronary Stents Average Prices ($)
13.19.5Austria Coronary Stents Company Shares, 2014
13.20 Others Europe Market for Coronary Stents Devices (2007-2020)
13.20.1Others Europe Coronary Stents Devices Cross Segment Analysis
13.20.2Others Europe Coronary Stents Revenue ($mn) by Segment
13.20.3Coronary Stents Volume (‘000) by Segment
13.20.4Coronary Stents Average Prices ($)
13.20.5Others Europe Coronary Stents Company Shares, 2014
13.21 Asia-Pacific Market for Coronary Stents (2007-2020)
13.21.1Asia-Pacific Coronary Stents Devices Cross Country Analysis
13.21.2Asia-Pacific Coronary Stents Company Shares, 2014
13.22 Japan Market for Coronary Stents Devices (2007-2020)
13.22.1Japan Coronary Stents Devices Cross Segment Analysis
13.22.2Japan Coronary Stents Revenue ($mn) by Segment
13.22.3Coronary Stents Volume (‘000) by Segment
13.22.4Coronary Stents Average Prices ($)
13.22.5Japan Coronary Stents Company Shares, 2014
13.23 China Market for Coronary Stents Devices (2007-2020)
13.23.1China Coronary Stents Devices Cross Segment Analysis
13.23.2China Coronary Stents Revenue ($mn) by Segment
13.23.3Coronary Stents Volume (‘000) by Segment
13.23.4Coronary Stents Average Prices ($)
13.23.5China Coronary Stents Company Shares, 2014
13.24 India Market for Coronary Stents Devices (2007-2020)
13.24.1India Coronary Stents Devices Cross Segment Analysis
13.24.2India Coronary Stents Revenue ($mn) by Segment
13.24.3Coronary Stents Volume (‘000) by Segment
13.24.4Coronary Stents Average Prices ($)
13.24.5India Coronary Stents Company Shares, 2014
13.25 Australia Market for Coronary Stents Devices (2007-2020)
13.25.1Australia Coronary Stents Devices Cross Segment Analysis
13.25.2Australia Coronary Stents Revenue ($mn) by Segment
13.25.3Coronary Stents Volume (‘000) by Segment
13.25.4Coronary Stents Average Prices ($)
13.25.5Australia Coronary Stents Company Shares, 2014
13.26 Israel Market for Coronary Stents Devices (2007-2020)
13.26.1Israel Coronary Stents Devices Cross Segment Analysis
13.26.2Israel Coronary Stents Revenue ($mn) by Segment
13.26.3Coronary Stents Volume (‘000) by Segment
13.26.4Coronary Stents Average Prices ($)
13.26.5Israel Coronary Stents Company Shares, 2014
13.27 Malaysia Market for Coronary Stents Devices (2007-2020)
13.27.1Malaysia Coronary Stents Devices Cross Segment Analysis
13.27.2Malaysia Coronary Stents Revenue ($mn) by Segment
13.27.3Coronary Stents Volume (‘000) by Segment
13.27.4Coronary Stents Average Prices ($)
13.27.5Malaysia Coronary Stents Company Shares, 2014
13.28 South Africa Market for Coronary Stents Devices (2007-2020)
13.28.1South Africa Coronary Stents Devices Cross Segment Analysis
13.28.2South Africa Coronary Stents Revenue ($mn) by Segment
13.28.3Coronary Stents Volume (‘000) by Segment
13.28.4Coronary Stents Average Prices ($)
13.28.5South Africa Coronary Stents Company Shares, 2014
13.29 Others Countries Market for Coronary Stents Devices (2007-2020)
13.29.1Others Countries Coronary Stents Revenue ($mn) by Segment
13.29.2Coronary Stents Volume (‘000) by Segment
14.Company Profiles
15.Recent Events
15.1 Product
15.2 Pipeline
15.3 Clinical Studies
15.4 Approvals
15.5 Deals
15.6 Patent Litigation
16.Appendix
16.1 Definitions
16.2 Abbreviation
16.3 Notes
17.Research Methodology
18.Disclaimer
List of Charts - 307
Some of the Chart Titles:-
Chart 1: In-depth classification of stents
Chart 2: Stent milestones
Chart 3: Stent placement procedure
Chart 4: Classification of coronary stents based on nature of material
Chart 5`: Desirable stent characteristics and possible complications
Chart 6: Major drivers and restrains for developed and developing geographies
Chart 7: Market players
Chart 8: Cobalt alloy platform - better than stainless steel
Chart 9: Evolution of polymer free DES
Chart 10: Unmet needs of DES
Chart 11: Newer generation of stents to overcome the unmet needs of BMS & DES
Chart 12: TINOX trial - late loss reduced by 39%
Chart 13: 12- and 36-month MACE composition
Chart 14: Bioabsorbable stents are expected to establish synergy between conflicting requirements
Chart 15: High unmet needs in existing stents led to invention of bioactive and bioabsorbable stents
Chart 16: Completely bioabsorbable stents may have drug or may be drug free
Chart 17: Growth of aging population in select countries
Chart 18: IHD mortality (33,744 deaths) versus usual total cholesterol by age
Chart 19: Rate of obesity in select countries in 2010
Chart 20: IHD mortality versus total cholesterol by BMI; systolic BP
Chart 21: Global diabetes burden
Chart 22: Growth of diabetic patients in matured and growing economies
Chart 23: Generation of stents
Chart 24: DREAMS provides scaffolding and paclitaxel release up to 3 months
Chart 25: Bioabsorption process of the BVS stent and relative degradation times
Chart 26: Growth of cardiovascular companies in emerging markets
Chart 27: Public healthcare expenditure
Chart 28: Longitudinal shortening, elongation and distortion of stents
Chart 29: Approvals driving the growth
Chart 30: Global, Coronary Stents Market (Value and Volume), 2007-2020
Chart 31: Global Coronary Stents, Revenue and Revenue Growth (2007-2020)
Chart 32: Global, Coronary Stents, Revenue ($mn), 2007-2014
Chart 33: Global, Coronary Stents, Revenue ($mn) , 2014-2020
Chart 34: Global, Coronary Stents, BMS, DES, Bioabsorbable stents Revenue 2007-2020
Chart 35: Global Coronary Stents, Volume (‘000) and Volume Growth (2007-2020)
Chart 36: Global, Coronary Stents, Volume (‘000) by Geographic Region, 2007-2014
Chart 37: Global, Coronary Stents, Volume (‘000) by Geographic Region ,2014-2020
Chart 38: Global, Coronary Stents, 2007-2020 Volume
Chart 39: Global, Coronary Stents, Company Shares (%), 2014
Chart 40: Americas, Coronary Stents, Revenue ($mn) by Country, 2007-2014
Chart 41: Americas, Coronary Stents, Revenue ($mn) by Country, 2014-2020
Chart 42: Americas, Coronary Stents, Company Shares (%), 2014
Chart 43: US, Coronary Stents, Cross Segment Analysis, 2007-2020
Chart 44: US, Coronary Stents, Revenue ($mn), 2007-2014
Chart 45: US, Coronary Stents, Revenue ($mn), 2014-2020
Chart 46: US, Coronary Stents, Volume (‘000), 2007-2014
Chart 47: US, Coronary Stents, Volume (‘000), 2014-2020
Chart 48: US, Coronary Stents, Average Prices ($), 2007-2020
Chart 49: US, Coronary Stents, Company Shares (%), 2014
Chart 50: Canada, Coronary Stents Cross-Segment Analysis, 2007-2020
Chart 51: Canada, Coronary Stents, Revenue ($mn), 2007-2014
Chart 52: Canada, Coronary Stents, Revenue ($mn), 2014-2020
Chart 53: Canada, Coronary Stents, Volume (‘000), 2007-2014
Chart 54: Canada, Coronary Stents, Volume (‘000), 2014-2020
Chart 55: Canada, Coronary Stents, Average Prices ($), 2007-2020
Chart 56: Canada, Coronary Stents, Company Shares (%), 2014
Chart 57: Brazil, Coronary Stents Cross-Segment Analysis, 2007-2020
Chart 58: Brazil, Coronary Stents, Revenue ($mn), 2007-2014
Chart 59: Brazil, Coronary Stents, Revenue ($mn), 2014-2020
Chart 60: Brazil, Coronary Stents, Volume, (‘000), 2007-2014
Chart 61: Brazil, Coronary Stents, Volume (‘000), 2014-2020
Chart 62: Brazil, Coronary Stents, Average Prices ($), 2007-2020
Chart 63: Brazil, Coronary Stents, Company Shares (%), 2014
Chart 64: Argentina, Coronary Stents Cross-Segment Analysis, 2007-2020
Chart 65: Argentina, Coronary Stents, Revenue ($mn), 2007-2014
Chart 66: Argentina, Coronary Stents, Revenue ($mn), 2014-2020
Chart 67: Argentina, Coronary Stents, Volume, (‘000), 2007-2014
Chart 68: Argentina, Coronary Stents, Volume (‘000), 2014-2020
Chart 69: Argentina, Coronary Stents, Average Prices ($), 2007-2020
Chart 70: Argentina, Coronary Stents, Company Shares (%), 2014
Chart 71: EUROPE, Coronary Stents, Revenue ($mn) by Country, 2007-2014
Chart 72: EUROPE, Coronary Stents, Revenue ($mn) by Country, 2014-2020
Chart 73: EUROPE, Coronary Stents, Company Shares (%), 2014
Chart 74: Germany, Coronary Stents Cross-Segment Analysis, 2007-2020
Chart 75: Germany, Coronary Stents, Revenue ($mn), 2007-2014
Chart 76: Germany, Coronary Stents, Revenue ($mn), 2014-2020
Chart 77: Germany, Coronary Stents, Volume (‘000), 2007-2014
Chart 78: Germany, Coronary Stents, Volume (‘000), 2014-2020
Chart 79: Germany, Coronary Stents, Average Prices ($), 2007-2020
Chart 80: Germany, Coronary Stents, Company Shares (%), 2014
Chart 81: France, Coronary Stents Cross-Segment Analysis, 2007-2020
Chart 82: France, Coronary Stents, Revenue ($mn), 2007-2014
Chart 83: France, Coronary Stents, Revenue ($mn), 2014-2020
Chart 84: France, Coronary Stents, Volume (‘000), 2007-2014
Chart 85: France, Coronary Stents, Volume (‘000), 2014-2020
Chart 86: France, Coronary Stents, Average Prices ($), 2007-2014
Chart 87: France, Coronary Stents, Company Shares (%), 2014
Chart 88: Italy, Coronary Stents Cross-Segment Analysis, 2007-2020
Chart 89: Italy, Coronary Stents, Revenue ($mn), 2007-2014
Chart 90: Italy, Coronary Stents, Revenue ($mn), 2014-2020
Chart 91: Italy, Coronary Stents, Volume (‘000), 2007-2014
Chart 92: Italy, Coronary Stents, Volume (‘000), 2014-2020
Chart 93: Italy, Coronary Stents, Average Prices ($), 2007-2020
Chart 94: Italy, Coronary Stents, Company Shares (%), 2014
Chart 95: UK, Coronary Stents Cross-Segment Analysis, 2007-2020
Chart 96: UK, Coronary Stents, Revenue ($mn), 2007-2014
Chart 97: UK, Coronary Stents, Revenue ($mn), 2014-2020
Chart 98: UK, Coronary Stents, Volume (‘000), 2007-2014
Chart 99: UK, Coronary Stents, Volume (‘000), 2014-2020
List of Tables
Some of the Table Titles:-
Table 1: Commonly used materials for coronary stents
Table 2: Biodegradable polymers offers low ST and better clinical outcomes over permanent polymers
Table 3: Stent approval status - US, EU and Japan
Table 4: Approvals
Table 5: Competitive landscape
Table 6: Competitive landscape
Table 7: Distribution of companies in four major geographies
Table 8: Stents undergoing clinical studies for the approvals
Table 9: Comparative trials - new v/s existing stents
Table 10: Clinical comparison and comparative trials (existing vs existing)
Table 11: Clinical studies under PMS and registries
Table 12: Pending one geography
Table 13: Existing stents in new and promising indications
Table 14: Innovations and approvals
Table 15: Regulatory approvals
Table 16: Comparison of results in on-label/off-label use of DES
Table 17: Partnership and alliance
Table 18: Mergers and acquisitions
Table 19: Global, Coronary Stents Market Size – Value and Volume, 2007-2014
Table 20: Global, Coronary Stents Market Size – Value and Volume, 2014-2020
Table 21: Global, Coronary Stents, Revenue and Revenue Growth (2007-2020)
Table 22: Global, Coronary Stents, Revenue ($mn) by Geographic Region, 2007-2014
Table 23: Global, Coronary Stents, Revenue ($mn) by Geographic Region ,2014-2020
Table 24: Global, Coronary Stents, Value ($mn) 2007-2014
Table 25: Global, Coronary Stents, Value ($mn) 2014-2020
Table 26: Global, Coronary Stents, Volume (‘000) and Growth (2007-2020)
Table 27: Global, Coronary Stents, Volume (‘000) by Geographic Region, 2007-2014
Table 28: Global, Coronary Stents, Volume (‘000) by Geographic Region, 2014-2020
Table 29: Global, Coronary Stents, Volume (‘000), 2007-2014
Table 30: Global, Coronary Stents, Volume (‘000), 2014-2020
Table 31: Global, Coronary Stents, Company Shares (%), 2014
Table 32: Americas, Coronary Stents, Revenue ($mn) by Country, 2007-2014
Table 33: Americas, Coronary Stents, Revenue ($mn) by Country, 2014-2020
Table 34: Americas, Coronary Stents, Company Shares (%), 2014
Table 35: US, Coronary Stents Cross-Segment Analysis, 2007-2020
Table 36: US, Coronary Stents, Revenue ($mn), 2007-2014
Table 37: US, Coronary Stents, Revenue ($mn), 2014-2020
Table 38: US, Coronary Stents, Volume (‘000), 2007-2014
Table 39: US, Coronary Stents, Volume (‘000), 2014-2020
Table 40: US, Coronary Stents, Average Prices ($ '000), 2007-2014
Table 41: US, Coronary Stents, Average Prices ($ '000), 2014-2020
Table 42: US, Coronary Stents, Company Shares (%), 2014
Table 43: Canada, Coronary Stents Cross-Segment Analysis, 2007-2020
Table 44: Canada, Coronary Stents, Revenue ($mn), 2007-2014
Table 45: Canada, Coronary Stents, Revenue ($mn), 2014-2020
Table 46: Canada, Coronary Stents, Volume (‘000), 2007-2014
Table 47: Canada, Coronary Stents, Volume (‘000), 2014-2020
Table 48: Canada, Coronary Stents, Average Prices ($), 2007-2014
Table 49: Canada, Coronary Stents, Average Prices ($ ), 2014-2020
Table 50: Canada, Coronary Stents, Company Shares (%), 2014
Table 51: Brazil, Coronary Stents Cross-Segment Analysis, 2007-2020
Table 52: Brazil, Coronary Stents, Revenue ($mn), 2007-2014
Table 53: Brazil, Coronary Stents, Revenue ($mn), 2014-2020
Table 54: Brazil, Coronary Stents, Volume (‘000), 2007-2014
Table 55: Brazil, Coronary Stents, Volume, (‘000), 2014-2020
Table 56: Brazil, Coronary Stents, Average Prices ($), 2007-2014
Table 57: Brazil, Coronary Stents, Average Prices ($), 2014-2020
Table 58: Brazil, Coronary Stents, Company Shares (%), 2014
Table 59: Argentina, Coronary Stents Cross-Segment Analysis, 2007-2020
Table 60: Argentina, Coronary Stents, Revenue ($mn), 2007-2014
Table 61: Argentina, Coronary Stents, Revenue ($mn), 2014-2020
Table 62: Argentina, Coronary Stents, Volume (‘000), 2007-2014
Table 63: Argentina, Coronary Stents, Volume (‘000), 2014-2020
Table 64: Argentina, Coronary Stents, Average Prices ($), 2007-2014
Table 65: Argentina, Coronary Stents, Average Prices ($), 2014-2020
Table 66: Argentina, Coronary Stents, Company Shares (%), 2014
Table 67: EUROPE, Coronary Stents, Revenue ($mn) by Country, 2007-2014
Table 68: EUROPE, Coronary Stents, Revenue ($mn) by Country, 2014-2020
Table 69: EUROPE, Coronary Stents, Company Shares (%), 2014
Table 70: Germany, Coronary Stents Cross-Segment Analysis, 2007-2020
Table 71: Germany, Coronary Stents, Revenue ($mn), 2007-2014
Table 72: Germany, Coronary Stents, Revenue ($mn), 2014-2020
Table 73: Germany, Coronary Stents, Volume (‘000), 2007-2014
Table 74: Germany, Coronary Stents, Volume (‘000), 2014-2020
Table 75: Germany, Coronary Stents, Average Prices ($), 2007-2014
Table 76: Germany, Coronary Stents, Average Prices ($), 2014-2020
Table 77: Germany, Coronary Stents, Company Shares (%), 2014
Table 78: France, Coronary Stents Cross-Segment Analysis, 2007-2020
Table 79: France, Coronary Stents, Revenue ($mn), 2007-2014
Table 80: France, Coronary Stents, Revenue ($mn), 2014-2020
Table 81: France, Coronary Stents, Volume (‘000), 2007-2014
Table 82: France, Coronary Stents, Volume (‘000), 2014-2020
Table 83: France, Coronary Stents, Average Prices ($), 2007-2014
Table 84: France, Coronary Stents, Average Prices ($), 2014-2020
Table 85: France, Coronary Stents, Company Shares (%), 2014
Table 86: Italy, Coronary Stents Cross-Segment Analysis, 2007-2020
Table 87: Italy, Coronary Stents, Revenue ($mn), 2007-2014
Table 88: Italy, Coronary Stents, Revenue ($mn), 2014-2020
Table 89: Italy, Coronary Stents, Volume (‘000), 2007-2014
Table 90: Italy, Coronary Stents, Volume (‘000), 2014-2020
Table 91: Italy, Coronary Stents, Average Prices ($), 2007-2014
Table 92: Italy, Coronary Stents, Average Prices ($), 2014-2020
Table 93: Italy, Coronary Stents, Company Shares (%), 2014
Table 94: UK, Coronary Stents Cross-Segment Analysis, 2007-2020
Table 95: UK, Coronary Stents, Revenue ($mn), 2007-2014
Table 96: UK, Coronary Stents, Revenue ($mn), 2014-2020
Table 97: UK, Coronary Stents, Volume (‘000), 2007-2014
Table 98: UK, Coronary Stents, Volume (‘000), 2014-2020
Table 99: UK, Coronary Stents, Average Prices ($), 2007-2014

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report